Zimvie Inc (ZIMV) Return on Assets ROA from the second quarter of 2025 to second quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket
 


Zimvie Inc   (NASDAQ: ZIMV)


Zimvie Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Zimvie Inc 's ROA in the second quarter of 2025?
Zimvie Inc recorded a cumulative net loss of $-19 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -2.8%.

However, within the Healthcare sector 233 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 2864, from total ROA ranking in the first quarter of 2025 at 2896.

What is ROA?



Return On Assets (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Total Assets Change -5.37 % -41.97 % -42.84 % -52.26 % -53.25 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -19 -20 -26 -349 -352
Return On Assets (TTM) -2.8 % -2.77 % -3.12 % -36.47 % -30.48 %
ZIMV's Total Ranking # 2864 # 2896 # 3391 # 4035 # 3956
Total Assets (TTM) in million 690 680 689 720 730
Seq. Total Assets Change 1.54 % -1.33 % -4.28 % -1.32 % -37.73 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 75
Sector # 234
Overall # 2825

Return On Assets Statistics
High Average Low
-2.54 %
-12.5 %
-35.33 %
(Mar 31 2025)   (Sep 30 2024)



  News about Zimvie Inc Return on Assets ROA

ZimVie Revolutionizes Implant Offerings with FDA Clearance and U.S. Launch of GenTek Restorative Components


Despite recording a cumulative net loss of $-67 million during the 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -4.27%, ZimVie remains determined to innovate and improve its product offerings. This recent FDA clearance holds great promise for the company, as it opens up new avenues for growth and expands its reach within the healthcare sector.
It is worth noting, however, that within the healthcare sector, there are 318 other companies currently boasting a higher return on assets compared to ZimVie. This suggests that ZimVie might face tough competition in the industry, but their commitment to enhancing their implant offerings might help them gain a competitive edge and improve their financial performance.




Financial Statements
Zimvie Inc 's Assets $ 690 million ZIMV's Balance sheet
Zimvie Inc 's Income $ -4 million Quarterly ZIMV's Income Statement
ZIMV's Income by Division See ZIMV's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021

FY
Y / Y Total Assets Change -42.84 % -31.62 % -3.5 % - -
Total Assets in million 689 1,205 1,763 1,827 0
Y / Y Net Income Change - - - - -
Net Income in million -26 -393 -64 -95 0
Annual Return On Assets -3.75 % -32.63 % -3.62 % -5.22 % -




More Return On Assets Ratios
ZIMV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZIMV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZIMV's Competitors
Subscribers only: Roa for Zimvie Inc 's Suppliers
Subscribers only: Return On Assets for ZIMV's Customers

You may also want to know
ZIMV's Roi ZIMV's Inventory Turnover Ratio ZIMV's Growth Rates ZIMV's Dividend Comparisons
ZIMV's Profitability Ratios ZIMV's Asset Turnover Ratio ZIMV's Dividend Growth
ZIMV's Roe ZIMV's Valuation Ratios ZIMV's Financial Strength Ratios ZIMV's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA


Date modified: 2026-09-18T13:11:06+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.